The Journal of Cerebral Blood Flow and Metabolism (JCBFM) has been successfully managed since 2009 by the co-Editors-in-Chief Martin Lauritzen (2009 present), Ulrich Dirnagl (2009 -2016 and Mhairi Macrae (2016-present) , and their editorial support staff. Their profound commitment and loyalty to the Journal, organizational skills, and original initiatives have effectively guided the Journal through the shifting landscape of scientific publishing. This fruitful era is now coming to a close, and a new editorial team will steer the ship from 1 January 2018 onwards, with transitions starting 1 July 2017.
The next editorial team will be directed by Jun Chen, the new Editor-in-Chief. He was selected after a rigorous search process, and the decision was announced at the BRAIN 2017 meeting in Berlin, organized by the International Society for Cerebral Blood Flow and Metabolism (ISCBFM). Dr. Chen is an Endowed Professor of Neurology and Pharmacology at the University of Pittsburgh School of Medicine (USA) and brings with him a wealth of experience in the fields of experimental, translational, and clinical neuroscience research. He has already served many roles at the ISCBFM and has been involved in editorial activities for numerous scientific journals. In his new role as Editor-in-Chief of the Journal, he will be assisted by a team of associate editors-Rick Dijkhuizen, PhD (University Medical Center Utrecht, The Netherlands), Peter Herscovitch, MD (National Institutes of Health, USA), Guohua Xi, MD (University of Michigan, USA), and Patrick Lyden, MD (Cedars-Sinai Medical Center, USA). A fifth associate editor is currently being recruited. In addition, Dr. Richard J. Traystman and Dr. Ulrich Dirnagl will serve as Consulting Editors.
The new editorial team is eager to make a profound difference to the Journal and is looking forward to guiding authors through the field of modern scientific publishing in collaboration with SAGE Publications. An important goal of the editorial team is to attract papers of the highest caliber from emerging research areas, while still maintaining the Journal's reputation and long-standing tradition in publishing high-quality articles on experimental, theoretical, and clinical aspects of brain circulation, metabolism, and imaging in health and disease. The editorial team intends to embrace novel publishing tools and strategies to modernize the Journal, and is hopeful that this will increase the Journal's appeal and widen its circulation. To ensure the highest level of scientific integrity and publication ethics, the reviews of submitted papers will involve not only experts in the specific area of the study but also statisticians and guideline reviewers, in line with evolving publishing standards.
The editorial team is optimistic about the new era of scientific publishing. Several exciting new developments include:
1. A new workflow for the manuscript handling system in which peer reviews are handled by associate editors who will make preliminary, mutually agreedupon decisions. Invitations for membership renewal will be sent each year, along with quantitative data on the member's review performance for the Journal.
The new editorial team is immensely grateful for the dedication, leadership, and achievements of Ulrich Dirnagl, Martin Lauritzen, and Mhairi Macrae. We are highly motivated to continue to promote and advance the Journal of Cerebral Blood Flow and Metabolism as a major platform for high-quality papers on basic, preclinical, and clinical neurovascular research.
Jun Chen is an Endowed Professor of Neurology and Pharmacology at the University of Pittsburgh School of Medicine. His special interest is in molecular and cellular mechanisms of mitochondrial dysfunction and neuronal cell death after brain ischemia, traumatic brain injury (TBI), or Parkinson's disease. His lab is currently investigating the mechanisms of post-stroke or post-TBI brain repair and functional recovery, with emphasis on the roles of microglial/macrophage responses, neuroinflammation, blood brain-barrier damage, and white matter injury. In the past decade, Dr Chen has served the International Society of Cerebral Blood Flow and Metabolism in various capacities.
Rick
Dijkhuizen His research involves multiparametric imaging of brain structure and function in health and disease, with emphasis on (1) preclinical development of tools for improved diagnosis of brain pathophysiology, (2) characterization of neural network (re)organization, and (3) Recently, Dr. Lyden's group characterized the toxic role played by thrombin and showed evidence of direct thrombin toxicity on neurons. Thrombin is made by injured neurons, and signals astrocytes to elicit a protective response. The second area is hypothermia. The Lyden lab has demonstrated that protection by hypothermia should be very quick, but brief; otherwise the protective effect of astrocytes on neurons is abrogated. Dr. Lyden's clinical research concerns quantitative methods of refining stroke scales and he was a key architect of the NIH Stroke Scale, used around the world to measure stroke severity. Dr. Lyden has been elected a Fellow of the American Academy of Neurology, American Neurology Association, American Heart Association, and the European Stroke Organization.
